糖尿病患者的肾移植：最终结果确实证明手段合理。

Renal transplantation in diabetic patients: the end result does justify the means.

作者信息

Sagalowsky A I, Gailiunas P, Helderman J H, Hull A R, Dickerman R M, Ransler C W, Atkins C, Peters P C

出版信息

J Urol. 1983 Feb;129(2):253-5. doi: 10.1016/s0022-5347(17)52036-4.

DOI:10.1016/s0022-5347(17)52036-4

Abstract

There were 49 insulin-dependent diabetics who received 52 renal allografts: 13 from living related and 39 from cadaveric donors. The mean age and time on dialysis were similar for both recipient groups. Patient survival at 1 and 2 years was 100 per cent for living related donor recipients, and 76 and 56 per cent at 1 and 2 years for cadaveric recipients. Renal allograft survival was 92 and 85 per cent at 1 and 2 years for living related donor recipients. Cadaveric allograft survival was 49 and 41 per cent at 1 and 2 years. The cumulative mortality rate was 39 per cent and the over-all surgical morbidity was low. Renal transplantation in diabetic patients is worthwhile from the standpoint of patient and allograft survival.

摘要

49例胰岛素依赖型糖尿病患者接受了52次肾移植：13例来自活体亲属供体，39例来自尸体供体。两个受者组的平均年龄和透析时间相似。活体亲属供体受者1年和2年的患者生存率为100%，尸体供体受者1年和2年的生存率分别为76%和56%。活体亲属供体受者肾移植1年和2年的生存率分别为92%和85%。尸体供体移植1年和2年的生存率分别为49%和41%。累积死亡率为39%，总体手术并发症发生率较低。从患者和移植肾存活的角度来看，糖尿病患者进行肾移植是值得的。